Drawing for PROGRESS-GT LOPD

USPTO serial 99436468

PROGRESS-GT LOPD

Reviewed by CopyMark Law Group

Status 645Office Action
Filing date
Status date
Registration date
—
Examiner
SMITH, BRENDAN K
Law office
TMEG LAW OFFICE 108

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 645: Status 645 means the USPTO mailed a final refusal maintaining at least one objection to your application. You can respond, appeal to the Trademark Trial and Appeal Board, or allow the application to abandon.

Need help with PROGRESS-GT LOPD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kristen Mollnow Walsh

Kristen Mollnow Walsh NIXON PEABODY LLP211 High Point Drive, Suite 110Victor, NY 14564-1061United States

Goods and services

ClassDescriptionStatusFirst use
035Clinical research services in the field of gene therapy, namely, the recruitment of patients for clinical trials; Patient recruitment for clinical trialsACTIVE—
042Providing medical and scientific research information; Providing medical and scientific research information about gene therapy and clinical trialsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 14, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 14, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 14, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 28, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 28, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 28, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 29, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 29, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 29, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 29, 2026ISMRWITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST—
May 5, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 5, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 29, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 8, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 11, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 11, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 11, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 28, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 28, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 28, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 27, 2026DOCKASSIGNED TO EXAMINER—
Feb 26, 2026MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Feb 26, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 10, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 10, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance